611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Cancer
Resources
Basic InformationLatest News
General, Central Obesity Linked to Specific Breast Cancer RiskProstate Cancer Symptoms Aren't Always ObviousCancer Treatment Can Affect Your Food PreferencesExpected Burden of Lung Cancer High for People Living With HIVNew Link Seen Between Gene Fusion and Bladder CancerSkin Cancer Prevention Strategies Needed in Work SettingsFDA Approves First Biosimilar Drug for CancerAliqopa Approved for Follicular LymphomaFibrous Dysplasia Associated With Increased Breast Cancer RiskU.S. Cancer Death Rate Continues to FallAACR Releases 2017 Cancer Progress ReportUSPSTF Backs Cervical Cancer Screening With Cytology or hrHPVMultivitamin Use May Cut Risk of Chemo-Induced NeuropathySurgeons Play Big Role in Women's Choices for Breast Cancer CareDabrafenib, Trametinib Beneficial in Resected MelanomaNew Guideline Aims to Help Doctors Diagnose Head, Neck MassesWidening Waistlines May Raise Women's Cancer RiskAdjuvant Nivolumab Tops Ipilimumab in MelanomaHPV Test Alone OK for Cervical Cancer Screening Over 30: Expert PanelCancer Drugs' High Prices Not Justified by Cost of Development, Study ContendsMedian Cost of Cancer Drug Development $648.0 MillionManaging Pain Can Be a Puzzle After Breast CancerImmune-Focused Drug May Be New Weapon Against Advanced MelanomaObamacare Paid Off for Poorer Cancer PatientsStrong Evidence for Healthy Lifestyle Reducing CRC RiskHere's the Recipe to Keep Colon Cancer at BayCRC Tumor Cells Exposed to Gut Bacteria Express ChemokinesUniversal Sequencing of Cancer Genes Ups Mutation DetectionMailed Invitations Increase CRC Screening CompletionInactivated Vaccinia Virus Shows Promise Against Advanced Cancer'Cancer Pen' Could Help Surgeons Spot Tumor Cells in SecondsCould the Zika Virus Help Battle a Deadly Brain Cancer?New Research Finds Value in PSA TestingHealth Tip: Diet and Activity May Help Prevent CancerFDA OKs Return of Once-Withdrawn Leukemia DrugLow Tumor Growth Rates During Active Surveillance of Thyroid CAScience Weighs in On How Fat Raises Cancer RiskFirst Gene Therapy Approved in U.S.Options Available for Estrogen Depletion After Breast CancerMoles Not Most Likely Spot for MelanomasAndrogen-Deprivation Therapy May Carry Cardiovascular RisksComputed Tomography Useful for Staging Head, Neck MelanomaCommon Treatment for Early Prostate Cancer May Carry Heart RiskCould Common Vitamin Supplements Raise Lung Cancer Risk?Females Show Better Response to CRT in Esophageal CancerOutdoor Nighttime Light Exposure Linked to Breast Cancer RiskArsenic Levels Higher in Patients With Nonmelanoma Skin CancersRadioiodine Therapy for Thyroid Cancer Doesn't Up Stroke RiskOne-Quarter With Early Breast Cancer Strongly Considers CPMFDA Approves New Treatment for Acute Lymphoblastic Leukemia
LinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Pain Management

More U.S. Women Living With Metastatic Breast Cancer


HealthDay News
Updated: May 18th 2017

new article illustration

THURSDAY, May 18, 2017 (HealthDay News) -- The number of U.S. women living with metastatic breast cancer has been rising since the 1990s, according to a study published online May 18 in Cancer Epidemiology, Biomarkers & Prevention.

The figures come from a U.S. surveillance system that tracks breast cancer mortality and survival. The researchers estimate that 154,794 U.S. women are living with metastatic breast cancer, up from 105,354 in 1990.

In the early 1990s, women diagnosed with metastatic breast cancer before age 50 typically lived for 22.3 months. By 2012, that had increased to 38.7 months, the investigators found. There was a similar pattern among women diagnosed between the ages of 50 and 64: Their typical survival rose from 19.1 months in the early 1990s to 29.7 months in 2012. More women are also surviving for prolonged periods. Among women diagnosed before age 50, the five-year survival rate doubled between 1992 and 2012 -- from 18 to 36 percent.

"The increasing burden of metastatic breast cancer highlights the importance of documenting recurrence to foster more research into the specific needs of this understudied population," the authors write.

Abstract/Full Text (subscription or payment may be required)